-
1 Comment
Deutsche Cannabis AG is currently in a long term downtrend where the price is trading 28.2% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, Deutsche Cannabis AG gets an overall score of 1/5.
Industry | Drug Manufacturers - Specialty & Generic |
---|---|
Exchange | F |
CurrencyCode | EUR |
ISIN | DE000A0BVVK7 |
Sector | Healthcare |
Market Cap | 5M |
---|---|
PE Ratio | None |
Target Price | None |
Beta | 3.05 |
Dividend Yield | None |
Deutsche Cannabis AG engages in the acquisition, sale, and management of investments in cannabis industry primarily in Germany. It also focuses on the investment in the renewable energy sector, such as photovoltaics and cogeneration. The company was formerly known as F.A.M.E. AG and changed its name to Deutsche Cannabis AG in December 2014. Deutsche Cannabis AG was founded in 1999 and is based in Hamburg, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HEMP.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025